Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18357530 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy
Condition: Minimal Hepatic Encephalopathy
Interventions: Drug: Acetyl-L-Carnitine;   Other: placebo

Indicates status has not been verified in more than two years